Quick Answer
Aquestive Therapeutics, Inc. reported Net Income of -$83.78 million for fiscal year 2025.
Aquestive Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$83.78M | -89.8% |
| 2024 | -$44.14M | -460.8% |
| 2023 | -$7.87M | +85.5% |
| 2022 | -$54.41M | +22.9% |
| 2021 | -$70.54M | -26.5% |
| 2020 | -$55.78M | +15.8% |
| 2019 | -$66.25M | -7.9% |
| 2018 | -$61.38M | -586.3% |
| 2017 | -$8.94M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$15.45M | -34.2% | -14.0% |
| June 30, 2025 | -$13.55M | -393.6% | +40.9% |
| March 31, 2025 | -$22.93M | -78.7% | -99.2% |
| September 30, 2024 | -$11.51M | -465.6% | -319.3% |
| June 30, 2024 | -$2.75M | +52.6% | +78.6% |
| March 31, 2024 | -$12.83M | -259.0% | -530.4% |
| September 30, 2023 | -$2.04M | +83.8% | +64.9% |
| June 30, 2023 | -$5.79M | +64.5% | -171.8% |
- Aquestive Therapeutics, Inc. showed a decrease of -89.8% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, Aquestive Therapeutics, Inc.’s net income has declined by 836.9% (from -$8.94 million to -$83.78 million).
- The most recent figure is from Aquestive Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: